Leukemia, Myelodysplasia, Transplantation
From the Journals
COVID-19 death rate was twice as high in cancer patients in NYC study
The overall case fatality rate was 28% for cancer patients with COVID-19 and 14% for noncancer COVID-19 patients.
From the Journals
Excess cancer deaths predicted as care is disrupted by COVID-19
Conference Coverage
Metastatic cancer linked to worse outcomes of COVID-19
Feature
EHA webinar addresses treating AML patients with COVID-19
Feature
ASCO panel outlines cancer care challenges during COVID-19 pandemic
From the Journals
Six million childhood cancer deaths could be prevented over the next 30 years
Researchers propose taking actions that could greatly reduce global childhood cancer deaths.
Feature
Will coronavirus restrictions lead to more advanced cancers?
News from the FDA/CDC
FDA approves ibrutinib-rituximab combo for newly diagnosed CLL, SLL in adults
Ibrutinib (Imbruvica) earns expanded indication for combination with rituximab as frontline treatment for adult CLL and SLL.
From the Journals
REACH2: Ruxolitinib outperformed control treatment for refractory acute GVHD
Ruxolitinib was significantly more effective against acute graft-versus-host disease but produced more thrombocytopenia than did control treatment...
From the Journals
Five prognostic indexes come up short for planning early CLL treatment
From the Journals
European cancer centers restructure care in the era of COVID-19